anonymous
Guest
anonymous
Guest
Civica Rx, said Thursday it plans to manufacture and sell generic versions of insulin (glargine, lispro and aspart) at no more than $30 per vial and $55 for five injector-pen cartridges, a fraction of list prices that currently range from $125 to more than $500. https://www.washingtonpost.com/business/2022/03/03/cheaper-insulin-plan/